Literature DB >> 7877977

Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion.

K Kamiya1, J Yasukawa-Barnes, J M Mitchen, M N Gould, K H Clifton.   

Abstract

Evidence is presented in support of the hypothesis that cancer development depends on an imbalance between highly frequent epigenetic initiation and suppression of promotion of the initiated cells. When irradiated clonogenic mammary epithelial cells are transplanted and hormonally stimulated, they give rise to clonal glandular structures within which carcinomas may arise. In the current study, the cancer incidence in grafts of approximately 13 7-Gy-irradiated clonogens per site indicated that at least 1 of approximately 95 clonogens was radiogenically initiated. A similar initiation frequency had been seen in grafts of approximately 5 methylnitrosourea (MNU)-treated clonogens. Such initiation is thus far more frequent than specific locus mutations. In sites grafted with larger cell inocula, cancer incidences per clonogen were suppressed inversely as the numbers of irradiated or MNU-treated clonogens per graft increased. Addition of unirradiated cells to small irradiated graft inocula also suppressed progression. Radiation and MNU thus produce quantitatively, and perhaps qualitatively, similar carcinogenesis-related sequelae in mammary clonogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877977      PMCID: PMC42513          DOI: 10.1073/pnas.92.5.1332

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Dynamics of neoplastic development in carcinogen-exposed tracheal mucosa.

Authors:  M Terzaghi; P Nettesheim
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

2.  X-RAY-INDUCED HERITABLE DAMAGE (SMALL-COLONY FORMATION) IN CULTURED MAMMALIAN CELLS.

Authors:  W K SINCLAIR
Journal:  Radiat Res       Date:  1964-04       Impact factor: 2.841

3.  Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation.

Authors:  D Medina; F Shepherd; T Gropp
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

4.  Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts.

Authors:  J R Landolph; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Is somatic mutation the major mechanism of malignant transformation?

Authors:  H Rubin
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

6.  Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells.

Authors:  A R Kennedy; M Fox; G Murphy; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

7.  Human cell hybrids: analysis of transformation and tumorigenicity.

Authors:  E J Stanbridge; C J Der; C J Doersen; R Y Nishimi; D M Peehl; B E Weissman; J E Wilkinson
Journal:  Science       Date:  1982-01-15       Impact factor: 47.728

8.  Radiogenic initiation of thyroid cancer: a common cellular event.

Authors:  R T Mulcahy; M N Gould; K H Clifton
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1984-05

9.  In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate.

Authors:  S Mondal; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1970-01       Impact factor: 11.205

10.  Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.

Authors:  S P Ethier; R L Ullrich
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

View more
  10 in total

Review 1.  The potential influence of radiation-induced microenvironments in neoplastic progression.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Epigenetics and breast cancer.

Authors:  B B Asch; M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

3.  Effect of oxidative DNA damage in promoter elements on transcription factor binding.

Authors:  R Ghosh; D L Mitchell
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density.

Authors:  H Rubin; A Yao; M Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymers.

Authors:  Alexander P Soneru; Michael A Beckett; Ralph R Weichselbaum; Raphael C Lee
Journal:  Health Phys       Date:  2011-12       Impact factor: 1.316

Review 6.  It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 7.  New biological insights on the link between radiation exposure and breast cancer risk.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-01-17       Impact factor: 2.673

Review 8.  Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.

Authors:  Ruthann A Rudel; Suzanne E Fenton; Janet M Ackerman; Susan Y Euling; Susan L Makris
Journal:  Environ Health Perspect       Date:  2011-06-22       Impact factor: 9.031

Review 9.  New highlights on stroma-epithelial interactions in breast cancer.

Authors:  Mary Helen Barcellos-Hoff; Daniel Medina
Journal:  Breast Cancer Res       Date:  2004-11-25       Impact factor: 6.466

Review 10.  Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection.

Authors:  Mauro Belli; Maria Antonella Tabocchini
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.